
Tenet Healthcare (THC) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
5.2B
Gross Profit
4.3B
82.63%
Operating Income
901.0M
17.25%
Net Income
622.0M
11.91%
EPS (Diluted)
$4.27
Balance Sheet Metrics
Total Assets
29.2B
Total Liabilities
20.6B
Shareholders Equity
8.7B
Debt to Equity
2.38
Cash Flow Metrics
Operating Cash Flow
832.0M
Free Cash Flow
642.0M
Revenue & Profitability Trend
Tenet Healthcare Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 20.7B | 20.5B | 19.2B | 19.5B | 17.6B |
Cost of Goods Sold | 3.6B | 3.6B | 3.3B | 3.3B | 3.0B |
Gross Profit | 17.0B | 17.0B | 15.9B | 16.2B | 14.7B |
Gross Margin % | 82.4% | 82.5% | 82.9% | 82.9% | 83.1% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 8.8B | 9.1B | 8.8B | 8.9B | 8.4B |
Other Operating Expenses | 4.5B | 4.5B | 3.8B | 4.0B | 3.2B |
Total Operating Expenses | 13.3B | 13.6B | 12.6B | 12.9B | 11.7B |
Operating Income | 2.9B | 2.4B | 2.4B | 2.4B | 2.1B |
Operating Margin % | 14.1% | 11.9% | 12.6% | 12.4% | 12.1% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 826.0M | 901.0M | 890.0M | 923.0M | 1.0B |
Other Non-Operating Income | 3.2B | 75.0M | -178.0M | 402.0M | -466.0M |
Pre-tax Income | 5.2B | 1.6B | 1.3B | 1.9B | 671.0M |
Income Tax | 1.2B | 306.0M | 344.0M | 411.0M | -97.0M |
Effective Tax Rate % | 22.6% | 18.9% | 25.6% | 21.8% | -14.5% |
Net Income | 4.1B | 1.3B | 1.0B | 1.5B | 768.0M |
Net Margin % | 19.7% | 6.4% | 5.2% | 7.6% | 4.4% |
Key Metrics | |||||
EBITDA | 4.1B | 3.6B | 3.5B | 3.5B | 3.2B |
EPS (Basic) | $33.02 | $6.01 | $3.84 | $8.55 | $3.80 |
EPS (Diluted) | $32.70 | $5.71 | $3.79 | $8.42 | $3.75 |
Basic Shares Outstanding | 96904000 | 101639000 | 106929000 | 106833000 | 105010000 |
Diluted Shares Outstanding | 96904000 | 101639000 | 106929000 | 106833000 | 105010000 |
Income Statement Trend
Tenet Healthcare Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 3.0B | 1.2B | 858.0M | 2.4B | 2.4B |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 2.5B | 2.9B | 2.9B | 2.8B | 2.7B |
Inventory | 346.0M | 411.0M | 405.0M | 384.0M | 368.0M |
Other Current Assets | 313.0M | 369.0M | 231.0M | 158.0M | 1.5B |
Total Current Assets | 7.7B | 7.2B | 6.0B | 7.1B | 7.1B |
Non-Current Assets | |||||
Property, Plant & Equipment | 6.0B | 6.2B | 6.3B | 5.9B | 1.6B |
Goodwill | 22.8B | 22.0B | 21.7B | 20.0B | 19.2B |
Intangible Assets | 1.4B | 1.4B | 1.4B | 1.5B | 1.6B |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 497.0M | 541.0M | 352.0M | 445.0M | 573.0M |
Total Non-Current Assets | 21.3B | 21.1B | 21.2B | 20.5B | 20.0B |
Total Assets | 28.9B | 28.3B | 27.2B | 27.6B | 27.1B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 1.3B | 1.4B | 1.5B | 1.3B | 1.2B |
Short-term Debt | 92.0M | 120.0M | 145.0M | 135.0M | 145.0M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 1.6B | 1.8B | 1.6B | 1.4B | 1.4B |
Total Current Liabilities | 4.3B | 4.8B | 4.5B | 5.1B | 4.8B |
Non-Current Liabilities | |||||
Long-term Debt | 13.1B | 14.9B | 14.9B | 15.5B | 15.6B |
Deferred Tax Liabilities | 227.0M | 326.0M | 217.0M | 36.0M | 29.0M |
Other Non-Current Liabilities | 1.6B | 1.7B | 1.8B | 1.4B | 1.6B |
Total Non-Current Liabilities | 16.1B | 18.0B | 18.1B | 18.2B | 19.4B |
Total Liabilities | 20.4B | 22.8B | 22.5B | 23.3B | 24.2B |
Equity | |||||
Common Stock | 8.0M | 8.0M | 8.0M | 8.0M | 7.0M |
Retained Earnings | 3.0B | -192.0M | -803.0M | -1.2B | -2.1B |
Treasury Stock | 3.5B | 2.9B | 2.7B | 2.4B | 2.4B |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 8.5B | 5.5B | 4.6B | 4.3B | 2.9B |
Key Metrics | |||||
Total Debt | 13.2B | 15.0B | 15.1B | 15.6B | 15.7B |
Working Capital | 3.4B | 2.4B | 1.5B | 2.0B | 2.3B |
Balance Sheet Composition
Tenet Healthcare Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 4.1B | 1.3B | 1.0B | 1.5B | 768.0M |
Depreciation & Amortization | 818.0M | 870.0M | 841.0M | 855.0M | 857.0M |
Stock-Based Compensation | 67.0M | 66.0M | 56.0M | 56.0M | 44.0M |
Working Capital Changes | 136.0M | 71.0M | -1.1B | -737.0M | 1.6B |
Operating Cash Flow | 5.0B | 2.4B | 997.0M | 1.9B | 2.9B |
Investing Activities | |||||
Capital Expenditures | 4.0B | -680.0M | -552.0M | 590.0M | -463.0M |
Acquisitions | -571.0M | -224.0M | -234.0M | -1.2B | -1.2B |
Investment Purchases | -94.0M | -104.0M | -92.0M | -108.0M | -44.0M |
Investment Sales | 63.0M | 50.0M | 76.0M | 31.0M | 59.0M |
Investing Cash Flow | 3.4B | -969.0M | -808.0M | -714.0M | -1.6B |
Financing Activities | |||||
Share Repurchases | -672.0M | -200.0M | -250.0M | 0 | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 23.0M | 1.4B | 2.0B | 2.9B | 3.8B |
Debt Repayment | -2.2B | -1.5B | -2.9B | -3.2B | -4.0B |
Financing Cash Flow | -3.7B | -1.0B | -1.8B | -936.0M | -355.0M |
Free Cash Flow | 1.1B | 1.6B | 321.0M | 910.0M | 2.9B |
Net Change in Cash | 4.7B | 381.0M | -1.6B | 237.0M | 890.0M |
Cash Flow Trend
Tenet Healthcare Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
11.18
Forward P/E
15.53
Price to Book
4.20
Price to Sales
0.76
PEG Ratio
0.59
Profitability Ratios
Profit Margin
7.18%
Operating Margin
16.13%
Return on Equity
29.65%
Return on Assets
7.58%
Financial Health
Current Ratio
1.71
Debt to Equity
158.70
Beta
1.52
Per Share Data
EPS (TTM)
$15.92
Book Value per Share
$42.44
Revenue per Share
$219.95
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
thc | 15.7B | 11.18 | 4.20 | 29.65% | 7.18% | 158.70 |
HCA Healthcare | 94.2B | 16.91 | -76.81 | 13,631.68% | 8.21% | -37.45 |
Encompass Health | 12.3B | 23.81 | 5.40 | 24.72% | 9.22% | 86.97 |
Universal Health | 11.6B | 9.62 | 1.65 | 18.79% | 7.66% | 70.09 |
DaVita | 9.8B | 13.45 | 6.68 | 57.94% | 6.35% | 825.19 |
Ensign Group | 9.6B | 30.10 | 4.72 | 17.54% | 7.00% | 100.93 |
Financial data is updated regularly. All figures are in the company's reporting currency.